Primary record
(2R)-2-HYDROXY-N-[(2S,3R,4E,8E)-3-HYDROXY-1-{[(2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}OCTADECA-4,8-DIEN-2-YL]HEXADECANAMIDE
- 库存
- 9,890 克
- 纯度
- 98.8 %
- CAS
- 114297-20-0
化合物标识与属性
- CAS
- 114297-20-0
- PubChem CID
- 11104507
- SMILES
- CCCCCCCCCCCCCC[C@H](C(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)[C@@H](/C=C/CC/C=C/CCCCCCCCC)O)O
- Canonical SMILES
- CCCCCCCCC/C=C/CC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)[C@H](O)CCCCCCCCCCCCCC
名称与同义词
- Soyacerebroside I
- Soya-cerebroside I
- SoyacerebrosideI
- Cerebroside B1a
- Soyacerebroside II
- Soya-cerebroside II
- 114297-20-0
- OVF1RF8S49
- orb1684207
- CHEMBL4203036
- SCHEMBL31229135
- C40H75NO9
- CHEBI:142276
- CHEBI:189690
- DTXSID401316286
- HY-N1228
- AS-1-4
- NP4345
- ZINC95918703
- AKOS040760717
- CID11104507
- DA-77951
- FS-10165
- J353.465K
- CS-0016615
- GLUCOSYL CERAMIDE, SOYACEREBROSIDE I-
- W1220
- J1.294.398I
- J3.407.850E
- GlcCer(d18:2(4E,8E)/16:0(2OH[R]))
- A1198859
- 1-O-glucopyranosyl-2-N-2'-hydroxyhexadecanoyl-4E,8E-sphingadienine
- (2R)-2-Hydroxy-N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]hexadecanamide
- 1-O-Glucopyranosyl-2-N-(2'-hydroxypalmitoyl)octadecasphinga-4,8-dienine
- 115074-93-6
- Hexadecanamide,N-[(1S,2R,3E,7E)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxy-,(2R)-
- N-(2R-hydroxyhexadecanoyl)-1-beta-glucosyl-4E,8E-octadecasphingadienine
- (4E,8E)-1-O-beta-D-Glucopyranosyl-N-[(2R)-2-hydroxyhexadecanoyl]-4,8-sphingadienine
- (4E,8E)-1-O-beta-D-Glucopyranosyl-N-[(2R)-2-hydroxyhexadecanoyl]-4,8-sphingenine
- (2R)-2-hydroxy-N-[(2S,3R)-3-hydroxy-1-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]hexadecanamide
- (2R)-2-hydroxy-N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]hexadecanamide
- (2R)-2-HYDROXY-N-[(2S,3R,4E,8E)-3-HYDROXY-1-{[(2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}OCTADECA-4,8-DIEN-2-YL]HEXADECANAMIDE
- (2R)-2-hydroxy-N-[(3R,4E,8E)-3-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]hexadecanamide
- (2R)-N-[(1S,2R,3E,7E)-1-[(beta-D-Glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadienyl]-2-hydroxyhexadecanamide
- (2R)-N-[(2S,3R,4E,8E)-1-(beta-D-Glucopyranosyloxy)-3-hydroxyoctadeca-4,8-dien-2-yl]-2-hydroxyhexadecanamide
- (2S,3R,4E)-1-(beta-D-Glucopyranosyloxy)-2-[[(R)-2-hydroxyhexadecanoyl]amino]-4,8-octadecadiene-3-ol
- (2S,3R,4E,8E)-1-(beta-D-Glucopyranosyloxy)-2-[[(2R)-2-hydroxypalmitoyl]amino]-4,8-octadecadiene-3-ol
- (2S,3R,4E,8E)-1-O-.BETA.-D-GLUCOPYRANOSYL-3-HYDROXY-2-(2'R-HYDROXYPALMITOYLAMINO)-4,8-OCTADECADIENE
- (R)-N-[(1S,2R)-1-(beta-D-Glucopyranosyloxymethyl)-2-hydroxy-3,7-heptadecadiene-1-yl]-2-hydroxyhexadecanamide
- (R)-N-[(1S,2R,3E,7E)-1-[(beta-D-Glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadienyl]-2-hydroxyhexadecanamide
- [(2S,3R,4E,8E)-2-[[(2R)-2-Hydroxyhexadecanoyl]amino]-3-hydroxy-4,8-octadecadienyl]beta-D-glucopyranoside
- HEXADECANAMIDE, N-((1S,2R,3E,7E)-1-((.BETA.-D-GLUCOPYRANOSYLOXY)METHYL)-2-HYDROXY-3,7-HEPTADECADIEN-1-YL)-2-HYDROXY-, (2R)-
- Hexadecanamide, N-[(1S,2R,3E,7Z)-1-[(beta-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxy-, (2R)-